Skip to main content

Scaffold Design

  • Chapter
  • First Online:
Biomedical Devices
  • 1461 Accesses

Abstract

The aim of tissue engineering is to create a working tissue for a replacement body part. Scaffold is the key biomedical device in tissue engineering applications, and in this chapter, we focus on scaffolds, including the key design parameters. In particular, a more detailed discussion on electrospinning is provided.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References and Further Reading

  1. Blitterswijk, C.A., Boer, J.: Tissue Engineering. Academic Press, Cambridge, MA, USA (2015)

    Google Scholar 

  2. Schwab, M.: Encyclopedia of Cancer. Springer, New York (2008)

    Google Scholar 

  3. Brandrup, J., Immergut, E.H., Grulke, E.A., Abe, A., Bloch, D.R.: Polymer Handbook, vol. 7. Wiley, New York (1989)

    Google Scholar 

  4. Sperling, L.H.: Introduction to Physical Polymer Science. Wiley, Hoboken (2005)

    Book  Google Scholar 

  5. Bosworth, L., Downes, S.: Electrospinning for Tissue Regeneration. Elsevier, Sawston, UK (2011)

    Book  Google Scholar 

  6. Burdick, J.A., Mauck, R.L.: Biomaterials for Tissue Engineering Applications: A Review of the Past and Future Trends. Springer, New York, NY, USA (2010)

    Google Scholar 

  7. Basu, B., Katti, D.S., Kumar, A.: Advanced Biomaterials: Fundamentals, Processing, and Applications. Wiley, Hoboken (2010)

    Google Scholar 

  8. Bártolo, P., Bidanda, B.: Bio-Materials and Prototyping Applications in Medicine. Springer, New York (2008)

    Book  Google Scholar 

  9. Subia, B., Kundu, J., Kundu, S.C.: Biomaterial Scaffold Fabrication Techniques for Potential Tissue Engineering Applications. IntechOpen (2010)

    Google Scholar 

  10. Minuth, W.W., Strehl, R., Schumacher, K.: Tissue Engineering: Essentials for Daily Laboratory Work. Wiley-VCH (2003)

    Google Scholar 

  11. O’Brien, F.: Biomaterials and scaffolds for tissue engineering. Mater. Today. 14, 88–95 (2011)

    Article  Google Scholar 

  12. Hollister, S.J.: Porous Scaffold Design for Tissue Engineering. Nat. Mater. 4, 518–524 (2005)

    Article  CAS  Google Scholar 

  13. Woodfield, T.B.F., Blitterswijk, C.V., Wijn, J.D., Sims, T.J., Hollander, A.P., Riesle, J.: Polymer scaffolds fabricated with pore-size gradients as a model for studying the zonal organization within tissue-engineered cartilage constructs. Tissue Eng. 11, 1297–1311 (2005)

    Article  CAS  Google Scholar 

  14. Teixeira, S., Ferraz, M.P., Monteiro, F.J.: Biocompatibility of highly macroporous ceramic scaffolds: cell adhesion and morphology studies. J. Mater. Sci. Mater. Med. 19, 855–859 (2008)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Problems

Problems

1.1 Problem 11.1

Consider the configuration of electrospinning for a highly porous biomaterial as a scaffold for tissue engineering applications. A polyvinylpyrrolidone (PVP) monomer solution of 10 ml (VD) needs to be deposited on the substrate material. The solution has a viscosity of 10 × 10−3 kg/m s and a density of 1.2 g/cm3. This solution should flow through a needle with a length of 1.5 cm (L) and an inner radius (Rb) of 0.5 mm. The radius of the plunger (Rp), where the force for fluid motion is obtained through pressure exerted by the thumb, is 5 mm. A calibration experiment was performed previously for the relation between the flow rate and the average fiber diameter produced by electrospinning as shown in Fig. 11.P1.

Fig. 11.P1
figure 13

Average fiber diameter against flow rate in the electrospinning process

In this question, we consider for manufacturing of a scaffold with a target fiber diameter of 800 nm.

  1. (a)

    What are the Reynolds number of the flow along (i) the cylinder and (ii) the needle?

  2. (b)

    What are the fluidic resistance (ΔP/Q) along (i) the cylinder and (ii) the needle?

  3. (c)

    Can you compare between the pressure drop in the cylinder and that in the needle?

  4. (d)

    What is the minimum required force applied to support the required rate of the liquid injection?

The polymerization process of PVP can be described as Fig. 11.P2 below:

Fig. 11.P2
figure 14

Polymerization of poly(vinyl-pyrrolidone)

Consider also the molar weight of the PVP polymer (Mw) is 43,000 g/mole and the atomic weights of the atoms listed below (Table 11.P1).

Table 11.P1 Atomic weights of the atoms found in poly(vinyl-pyrrolidone)
  1. (e)

    What type of polymerization should this process be and why?

  2. (f)

    What is the degree of polymerization (DP)?

1.2 Problem 11.2

A sample for 3D printing of a scaffold is prepared by dissolving 0.10 g of polystyrene (molecular weight: 4.26 × 106 g/mol) in 100 ml of butanone. The sample has a viscosity 1.273 times of the pure butanone. Given the empirical values of KP and ap in the Mark-Houwink-Staudinger relation have been previously obtained as 3.9 × 10−3 and 0.58, respectively, what is the sample viscosity?

1.3 Problem 11.3

The extension ratios (= λ) for four different molar masses (MP) of polyisobutylene in cyclohexane obtained at 30 °C are listed in Table 11.P2. Check that these data are consistent with Eq. 11.14.

Table 11.P2 Extension ratios (λ) for different molar masses (MP) of polyisobutylenein cyclohexane

1.4 Problem 11.4

Imagine that you are responsible for manufacturing an artificial bone for replacement of a bone fragment missing in the skull of a patient who had a serious injury in a car accident. A surgery was performed previously to remove a broken piece of bone. During the primary bone healing of the patient, your role is to manufacture a scaffold for the subsequent bone cell seeding and culture in order to develop the in vitro artificial bone. In the next surgery, this artificial bone will be placed at the missing location of the skull for sealing the skull.

  1. (a)

    Before the manufacturing, imaging of the skull should be performed to obtain the 3D geometry of the missing part of the bone. Can you suggest a bio-imaging method? Please describe briefly the working principle.

  2. (b)

    The scaffold was then fabricated by a rapid prototyping machine. The substrate material you could use is the composite of hydroxyapatite and PEG-PLA-PEG. Figure 11.P3 is showing the chemical synthesis of PEG-PLA-PEG. What kind of the polymerization is involved in this process? Please explain.

  3. (c)

    The composite should include mostly PEG-PLA-PEG, whose viscosity (μ) is ~8.872 × 10−3 kg/m·s. During the rapid prototyping process, the composite should be applied onto the sample for deposition using a syringe. The injection operation was controlled by a computer. The composite solution should flow through a syringe needle with a length of 0.1 mm (L) and an inner radius (Rb) of 0.1 mm. The radius of the plunger (Rp), where the force for fluid motion is obtained through pressure exerted by the thumb, is 1 cm. Assume that the solution flow rate is 5 nL/h. What is the minimum required force applied to support the required rate of the liquid injection?

  4. (d)

    The missing piece of bone had the shape as a quarter of a circular disc as shown below. Taking into account that a bone cell should have a diameter ~10 μm, the scaffold should have the separating hole/gap widths Dgap such that the cells can deposit and migrate inside the scaffold. Please design for scaffold and the corresponding path of the extruder/syringe needle for the fabrication.

    Fig. 11.P4
    figure a

    Geometry of a missing piece of bone

  5. (e)

    Please express the porosity of the scaffold as a function of Dgap.

  6. (f)

    Considering that the cured scaffold material has the Young’s modulus close to cure PLA (EPLA = 3.5 GPa), please express the equivalent compressive stiffness of the scaffold as a function of Dgap.

  7. (g)

    Based on the design and fabrication strategy you provided in part (d) and further considering the injection flow rate of the composite (as mentioned in part (c)) is now flexible (no longer fixed as 5 nL/h), denoted as Q, please estimate for the manufacturing time.

  8. (h)

    To achieve a functional scaffold, the allowable Dgap should be ≥30 μm such that cells can migrate into the inner scaffold body. The equivalent compressive stiffness Escaffold of the scaffold should be ≥0.5 GPa to maintain the structural shape after implantation. The patient’s injury site would need the scaffold dimensions of Rscaffold = 2 cm and Hscaffold = 3 mm. Furthermore, the flow rate Q can only be set ≤10 nL/h by the injection system. Given all these parameter settings/constraints, can you find out a set of feasible operation parameters and manufacturing time for your scaffold design? Please show how you obtain the results.

Fig. 11.P3
figure 15

Polymerization of PEG-PLA-PEG

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lam, R.H.W., Chen, W. (2019). Scaffold Design. In: Biomedical Devices. Springer, Cham. https://doi.org/10.1007/978-3-030-24237-4_11

Download citation

Publish with us

Policies and ethics